Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Mar-24 4:09 PM View:  | Charles River Laboratories ... (CRL) | 01-Mar-24 | Gift | 412 | -- | -- | (1%) 34.1K to 33.69K | |
| 04-Mar-24 4:09 PM View: | Charles River Laboratories ... (CRL) | 29-Feb-24 | Private Sale | 3,786 | $253.45 | $959,545.00 | (10%) 37.88K to 34.1K | |
| 20-Feb-24 5:32 PM View: | Charles River Laboratories ... (CRL) | 15-Feb-24 | Option Exercise | 5,882 | $144.67 | $850,949.00 | 16% 37.88K to 43.77K | (9%) |
| 20-Feb-24 5:32 PM View: | Charles River Laboratories ... (CRL) | 15-Feb-24 | Private Option Sale | 5,882 | $241.21 | $1,418,770.00 | (13%) 43.77K to 37.88K | |
| 31-Jan-24 7:35 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 2,115 | -- | -- | 6% 36.32K to 38.44K | |
| 31-Jan-24 7:35 PM View: | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 555 | $220.28 | $122,255.00 | (1%) 38.44K to 37.88K | |
| 31-May-23 1:21 PM View: | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 110 | $194.12 | $21,353.20 | (1%) 7.4K to 7.29K | |
| 31-May-23 1:21 PM View: | Charles River Laboratories ... (CRL) | 28-May-23 | Payment of Exercise | 71 | $194.12 | $13,782.50 | (< 1%) 7.47K to 7.4K | |
| 31-May-23 1:21 PM View: | Charles River Laboratories ... (CRL) | 27-May-23 | Payment of Exercise | 105 | $194.12 | $20,382.60 | (1%) 7.57K to 7.47K | |
| 31-May-23 1:21 PM View: | Charles River Laboratories ... (CRL) | 26-May-23 | Grant | 1,700 | -- | -- | 29% 5.87K to 7.57K | |
| 22-Feb-23 5:02 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-23 | Payment of Exercise | 136 | $243.60 | $33,129.60 | (< 1%) 35.05K to 34.91K | |
| 21-Feb-23 5:39 PM View: | Charles River Laboratories ... (CRL) | 16-Feb-23 | Option Exercise | 4,558 | $109.34 | $498,372.00 | 13% 35.05K to 39.6K | |
| 21-Feb-23 5:39 PM View: | Charles River Laboratories ... (CRL) | 16-Feb-23 | Planned Option Sale | 4,558 | $254.41 | $1,159,620.00 | (12%) 39.6K to 35.05K | |
| 30-Jan-23 6:07 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Grant | 4,820 | -- | -- | 15% 31.54K to 36.35K | |
| 30-Jan-23 6:07 PM View: | Charles River Laboratories ... (CRL) | 27-Jan-23 | Payment of Exercise | 1,309 | $244.49 | $320,037.00 | (4%) 36.35K to 35.05K | |
| 17-Nov-22 5:22 PM View: | Charles River Laboratories ... (CRL) | 15-Nov-22 | Option Exercise | 2,279 | $109.34 | $249,186.00 | 7% 31.54K to 33.81K | |
| 17-Nov-22 5:22 PM View: | Charles River Laboratories ... (CRL) | 15-Nov-22 | Planned Option Sale | 2,279 | $249.90 | $569,522.00 | (7%) 33.81K to 31.54K |